Recent News

• 06.02.2026 - Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
• 05.01.2026 - Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
• 04.02.2026 - Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 05.21.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.21.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2026 - 144 Report of proposed sale of securities
• 05.20.2026 - 144 Report of proposed sale of securities
• 05.13.2026 - 8-K Current report
• 05.13.2026 - EX-99.1 EX-99.1
• 05.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.07.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.06.2026 - 4 Statement of changes in beneficial ownership of securities